// App-Quantinova.ai

: Natriuretic Peptide-Based Inclusion Criteria in COMMANDER-HF Trial

Researchers

Presenter

  • Cunningham JW

Principal Investigators

  • Ferreira JP

  • Deng H

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Congestive heart failure

  • Stroke

Biomarkers

  • B-type natriuretic peptide

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved